Readmission Following Prostatic Surgery
- Conditions
- BPH With Urinary Obstruction
- Interventions
- Procedure: TUIPProcedure: TURPProcedure: AEEPProcedure: Prostate Vaporization
- Registration Number
- NCT06101576
- Lead Sponsor
- Mansoura University
- Brief Summary
This study will be conducted to estimate readmission rate and reasons for readmission after all modalities of endoscopic transurethral surgeries for treatment of BOO secondary to BPH in the last 20 years.
- Detailed Description
Computerized patient information system (PIS) of Urology and Nephrology Center (UNC) and database of prostate unit of UNC will be reviewed for all preoperative, intraoperative and post discharge data. All follow up visits will be traced for outcome measurement. Patients with no hospital follow up visit will be contacted by phone and interrogated about their LUTS control state, ongoing medication and history of secondary procedures.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Male
- Target Recruitment
- 4000
Men who underwent transurethral prostatic surgery for BPH causing BOO at Urology and Nephrology Center, Mansoura University, Egypt from Jun. 2005 to Dec. 2024.
- Patients who underwent TUR tunnelling for prostatic adenocarcinoma.
- LUTS secondary to neuropathic bladder.
- Incidentally diagnosed prostate cancer after surgery
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Transurethral incision of the prostate (TUIP) TUIP Patients who underwent TUIP using electrocautery or Laser. Transurethral resection of the prostate (TURP) TURP Patients who underwent TURP using monopolar or bipolar electrocautery. Anatomical endoscopic enucleation of the prostate (AEEP) AEEP Patient who underwent anatomical endoscopic enucleation of the prostate (AEEP) using Holmium, Thulium or GreenLight laser or bipolar current. Prostate Vaporization Prostate Vaporization Patient who underwent vaporization of the prostate using plasma or laser energy (GreenLight PVP and Thulium vaporization of the prostate).
- Primary Outcome Measures
Name Time Method The need for post discharge hospital readmission. 90 days The need for post discharge hospital readmission after surgery.
- Secondary Outcome Measures
Name Time Method Differences of readmission rates 90 days Difference of readmission rates for different modalities of transuretheral prostatic surgery.
Change in the causes of readmission over time. 20 years Change in the causes of readmission over time.
Causes and predictors of readmission. 90 days Causes and predictors of readmission.
Trial Locations
- Locations (1)
Urology and Nephrology Center
🇪🇬Mansoura, Egypt